AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma ... market for smart inhaler devices ...

According to a new research study published in Science, the EBCare smart mask analyzes the chemicals in your breath to ...

Viewing and monitoring treatment frequency and technique is important, according to Teva, as data shows that patients with asthma overestimate actual inhaler use by up to eight inhalations per week.

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Although it is recognized that airway inflammation is key to asthma pathogenesis, the marked heterogeneity in its clinical course and variations in response to treatment make it a challenging ...

A new study published in the journal Science reports that scientists have created a mask-based device to help monitor biomarkers for certain medical conditions such as COPD and asthma by analyzing ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...

Allergy specialist care lowers asthma emergency risks in children on Medicaid, highlighting its value in management.